miR-125b has been found to upregulate peroxiredoxin-like 2A (PRXL2A), an antioxidant protein commonly upregulated in oral squamous cell carcinoma (OSCC), which inhibits the cellular oxidative damage by positive regulation of the Nrf2 signaling pathway [116]. This evidence concerns the gene PRXL2A and oral cavity squamous cell carcinoma.